Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries

STUDY QUESTION Is it possible to restore ovarian function and natural fertility following the cryopreservation and autotransplantation of whole ovaries, complete with vascular pedicle, in adult females from a large monovulatory animal model species (i.e. sheep)? SUMMARY ANSWER Full (100%) restoration of acute ovarian function and high rates of natural fertility (pregnancy rate 64%; live birth rate 29%), with multiple live births, were obtained following whole ovary cryopreservation and autotransplantation (WOCP&TP) of adult sheep ovaries utilizing optimized cryopreservation and post-operative anti-coagulant regimes. WHAT IS KNOWN ALREADY Fertility preservation by WOCP&TP requires successful cryopreservation of both the ovary and its vascular supply. Previous work has indicated detrimental effects of WOCP&TP on the ovarian follicle population. Recent experiments suggest that these deleterious effects can be attributed to an acute loss of vascular patency due to clot formation induced by damage to ovarian arterial endothelial cells. STUDY DESIGN, SIZE, DURATION Study 1 (2010–2011; N = 16) examined the effect of post-thaw perfusion of survival factors (angiogenic, antioxidant, anti-apoptotic; n = 7–8) and treatment with aspirin (pre-operative versus pre- and post-operative (n = 7–9)) on the restoration of ovarian function for 3 months after WOCP&TP. Study 2 (2011–2012; N = 16) examined the effect of cryoprotectant (CPA) perfusion time (10 versus 60 min; n = 16) and pre- and post-operative treatment with aspirin in combination with enoxaparine (Clexane®; n = 8) or eptifibatide (Integrilin®; n = 8) on ovarian function and fertility 11–23 months after WOCP&TP. PARTICIPANTS/MATERIALS, SETTING, METHODS Both studies utilized mature, parous, Greyface ewes aged 3–6 years and weighing 50–75 kg. Restoration of ovarian function was monitored by bi-weekly blood sampling and display of behavioural oestrus. Blood samples were assayed for gonadotrophins, progesterone, anti-Müllerian Hormone and inhibin A. Fertility restoration in Study 2 was quantified by pregnancy rate after a 3 month fertile mating period and was confirmed by ultrasound, hormonal monitoring and live birth. Ovarian function was assessed at sacrifice by ovarian appearance and vascular patency (Doppler ultrasound) and by follicular histology. MAIN RESULTS AND THE ROLE OF CHANCE In Study 1, survival factors were found to have no benefit, but the inclusion of pre-operative aspirin resulted in four ewes showing acute restoration of ovarian function within 3 weeks and a further six ewes showing partial restoration. The addition of post-operative aspirin alone had no clear benefit. In Study 2, combination of aspirin with additional post-operative anti-coagulants resulted in total acute restoration of ovarian function in 14/14 ewes within 3 weeks of WOCP&TP, with 9/14 ewes becoming pregnant and 4/14 giving birth to a total of seven normal lambs. There was no difference between anti-coagulants in terms of restoration of reproductive function and fertility. In contrast, the duration of CPA perfusion was highly significant with a 60 min perfusion resulting in ovaries of normal appearance and function with high rates of primordial follicle survival (70%) and an abundant blood supply, whereas ovaries perfused for 10 min had either resorbed completely and were vestigial (7/14) or were markedly smaller (P < 0.01). It is concluded that both the degree of CPA penetration and the maintenance of post-operative vascular patency are critical determinants of the success of WOCP&TP. LIMITATIONS, REASONS FOR CAUTION Before application of this technology to fertility preservation patients, it will be critical to optimize the CPA perfusion time for different sized human ovaries, determine the optimum period and level of anti-coagulant therapy, and confirm the normality of offspring derived from this procedure. WIDER IMPLICATIONS OF THE FINDINGS This technology holds promise for the preservation of fertility in women. It could also potentially be applied to the cryopreservation of other reproductive or even major organs (kidneys) where there are considerable difficulties in storing donated tissue. STUDY FUNDING/COMPETING INTEREST(S) Funding was received from the Medical Research Council, University of Nottingham. The authors confirm that they have no conflict of interest in relation to this work.

[1]  Claus Yding Andersen,et al.  Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.

[2]  C. Pincott-Allen,et al.  The effects of whole ovarian perfusion and cryopreservation on endothelial cell-related gene expression in the ovarian medulla and pedicle. , 2013, Molecular human reproduction.

[3]  S. Silber Ovary cryopreservation and transplantation for fertility preservation. , 2012, Molecular human reproduction.

[4]  E. Ernst,et al.  The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. , 2010, Human reproduction.

[5]  Guoyao Wu,et al.  Novel pathways for implantation and establishment and maintenance of pregnancy in mammals. , 2010, Molecular human reproduction.

[6]  V. Onions,et al.  Ovarian endocrine profile and long-term vascular patency following heterotopic autotransplantation of cryopreserved whole ovine ovaries. , 2009, Human reproduction.

[7]  Thomas W. Kelsey,et al.  Human Ovarian Reserve from Conception to the Menopause , 2009, PloS one.

[8]  N. Desai,et al.  Reproductive outcome after transplantation of ovarian tissue: a systematic review. , 2008, Human reproduction.

[9]  C. Ottosen,et al.  Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. , 2008, Human reproduction.

[10]  B. Campbell,et al.  Ovarian tissue viability following whole ovine ovary cryopreservation: assessing the effects of sphingosine-1-phosphate inclusion. , 2008, Human reproduction.

[11]  S. Emiliani,et al.  Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. , 2007, The oncologist.

[12]  J. Donnez,et al.  Cryopreservation of intact human ovary with its vascular pedicle--or cryopreservation of hemiovaries? , 2007, Human reproduction.

[13]  J. Donnez,et al.  Laparoscopic ovariectomy for whole human ovary cryopreservation: technical aspects. , 2007, Fertility and sterility.

[14]  E. Fridman,et al.  Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. , 2007, Fertility and sterility.

[15]  T. Falcone,et al.  Cryopreservation of intact human ovary with its vascular pedicle. , 2006, Human reproduction.

[16]  H. Bergmeister,et al.  Orthotopic microvascular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. , 2006, Fertility and sterility.

[17]  Y. Nathan,et al.  Oocyte recovery, embryo development and ovarian function after cryopreservation and transplantation of whole sheep ovary. , 2005, Human reproduction.

[18]  A. Arav,et al.  Whole sheep ovary cryopreservation and transplantation. , 2004, Fertility and sterility.

[19]  J. Donnez,et al.  Livebirth after orthotopic transplantation of cryopreserved ovarian tissue , 2004, The Lancet.

[20]  B. Campbell,et al.  Evidence of a role for follicle-stimulating hormone in controlling the rate of preantral follicle development in sheep. , 2004, Endocrinology.

[21]  M. C. Carr,et al.  The emergence of the metabolic syndrome with menopause. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  T. Falcone,et al.  Restoration of ovarian function after autotransplantation of intact frozen-thawed sheep ovaries with microvascular anastomosis. , 2003, Fertility and sterility.

[23]  D. Baird,et al.  Production of inhibin A not B in rams: changes in plasma inhibin A during testis growth, and expression of inhibin/activin subunit mRNA and protein in adult testis. , 2002, Reproduction.

[24]  D E Pegg,et al.  The History and Principles of Cryopreservation , 2002, Seminars in reproductive medicine.

[25]  C. Poirot,et al.  Are there indications for ovarian tissue cryopreservation? , 2001, Fertility and sterility.

[26]  M. Soules,et al.  The future of human ovarian cryopreservation and transplantation: fertility and beyond. , 2001, Fertility and sterility.

[27]  N. Groome,et al.  Plasma Inhibin A in Heifers: Relationship with Follicle Dynamics, Gonadotropins, and Steroids During the Estrous Cycle and after Treatment with Bovine Follicular Fluid1 , 2001, Biology of reproduction.

[28]  M. Faddy,et al.  Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation. , 1998, Human reproduction.

[29]  B. Campbell,et al.  The effect of ovarian arterial infusion of transforming growth factor alpha on ovarian follicle populations and ovarian hormone secretion in ewes with an autotransplanted ovary. , 1994, The Journal of endocrinology.

[30]  R. Webb,et al.  Restoration of fertility to oophorectomized sheep by ovarian autografts stored at-196°C , 1994 .

[31]  D. Pee,et al.  Early menopause in long‐term survivors of cancer during adolescence , 1992, American journal of obstetrics and gynecology.

[32]  N. Groome,et al.  Monoclonal and polyclonal antibodies reactive with the 1-32 amino terminal sequence of the alpha subunit of human 32K inhibin. , 1990, Hybridoma.

[33]  B. Rubinsky,et al.  A mathematical model for the freezing process in biological tissue. , 1988, Proceedings of the Royal Society of London. Series B, Biological sciences.

[34]  J. Annegers,et al.  Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.

[35]  D. Pegg Perfusion of rabbit kidneys with cryoprotective agents. , 1982, Cryobiology.

[36]  D. Baird,et al.  Prostaglandin F 2 identified as a luteolytic hormone in sheep. , 1972, Nature: New biology.

[37]  D. Baird,et al.  Functional assessment of autotransplanted endocrine organs. , 1972, Acta endocrinologica. Supplementum.

[38]  D. Pegg Principles of cryopreservation. , 2015, Methods in molecular biology.

[39]  H. Zeyneloglu,et al.  Whole Ovary Cryopreservation , 2012 .

[40]  P. Patrizio,et al.  Ovarian function 6 years after cryopreservation and transplantation of whole sheep ovaries. , 2010, Reproductive biomedicine online.

[41]  S. S. Kim,et al.  Cryopreservation of gonadal tissue and cells. , 2000, British medical bulletin.

[42]  B. Campbell,et al.  Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196 C. , 1999, Endocrinology.

[43]  B. Campbell,et al.  Long-Term Ovarian Function in Sheep after Ovariectomy and Transplantation of Autografts Stored at -196 C* * This work was supported by Medical Research Council Program Grant 8929853. , 1999, Endocrinology.

[44]  R. Gosden,et al.  Gonadal tissue cryopreservation: clinical objectives and practical prospects. , 1999, Human fertility.

[45]  B. Campbell,et al.  Effects of dose of LH on androgen production and luteinization of ovine theca cells cultured in a serum-free system. , 1998, Journal of reproduction and fertility.

[46]  D. Baird,et al.  Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. , 1994, Human reproduction.

[47]  P. Mattner,et al.  Effects of ovarian hormones on ovarian capillary blood flow in anoestrous ewes. , 1984, Australian journal of biological sciences.